# A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

> **NCT05470101** · PHASE1 · COMPLETED · sponsor: **Intra-Cellular Therapies, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ITI-333

## Key facts

- **NCT ID:** NCT05470101
- **Lead sponsor:** Intra-Cellular Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-26
- **Primary completion:** 2023-05-03
- **Final completion:** 2023-05-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470101, "A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05470101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*